Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs
AbstractTreatment-induced sexual dysfunctions (SD) are a recurrent and controversial topic in recent literature on the adverse events related to the use of 5-alpha-reductase inhibitors (5ARIs) (1, 2). In order to deal adequately with the various aspects of this topic, it is necessary to first cover some of the steps that allow a better definition and understanding of the subject.
- Abstract views: 3492
- PDF: 2680
Copyright (c) 2016 Furio Pirozzi Farina, Antonella Pischedda
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.